FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for ...
Zacks.com on MSN5h
Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Novavax (NVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX). Such investors are advised to ...
Novavax, Inc.: U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today ...
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for ...
KTLA5d
Did Novavax, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- NVAX
NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novavax ... Following this news, NVAX's stock price fell by $2.18 ...
Le Lézard6h
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-Mtm adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on ...
Bank of America Securities Sticks to Their Buy Rating for Sana Biotechnology (SANA)
In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Sana Biotechnology (SANA – Research ...
J.P. Morgan Keeps Their Hold Rating on Verve Therapeutics (VERV)
In a report released yesterday, Eric Joseph from J.P. Morgan maintained a Hold rating on Verve Therapeutics (VERV – Research Report), ...
Fox 44 Waco News6d
Novavax to Host Conference Call to Discuss Third
Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call. To ensure a timely connection, it is recommended that ...